Clinical Laboratory Tests Market Is Increasing Due To Increasing Prevalence Of Chronic Diseases Till 2024: Grand View Research, Inc.
The
global clinical laboratory tests market is expected to
reach USD 198.5 billion by 2024, based on a new study by Grand View Research,
Inc. Introduction of innovative solutions on the grounds of maximum efficiency
and minimum error is expected to serve this market as a high impact-rendering
driver.
Integrated
workflow management systems, database management tools and patient test records
are becoming increasingly important in the healthcare industry with companies
processing as many as 100 to 150 billion samples per year.
U.S. clinical laboratory tests market, by type, 2013 - 2024 (USD Billion) |
Development
and implementation of various informatics and data management solutions for
performing seamless operations is expected to drive the growth of this market.
Availability of technologically advanced products such as chemistry analyzers
with high yield, low maintenance and, ease of usage has heightened the demand
for early disease detection.
Increasing
prevalence of chronic diseases and the consequent need to curb healthcare
expenditure is also expected to drive market growth by increasing the demand
for early and regular disease diagnosis. Moreover, presence of favorable
reimbursement policies and availability of CLIA waived test is anticipated to
increase base of target population.
Browse full
research report on Clinical Laboratory Tests Market: www.grandviewresearch.com/industry-analysis/clinical-laboratory-tests-market
Further key findings from the report suggest:
- The
basic metabolic panel segment dominated the clinical laboratory test
market in 2015 mainly due to high acceptance rate of this panel of tests
- Liver
panel is estimated to witness highest growth for liver cirrhosis testing
owing to high rate of alcohol consumption
- Increasing
demand for testing of blood lipid levels in cardiovascular and diabetes
patients is anticipated to attribute towards significant growth of liver
panel over the forecast period.
- Extensive
support of manpower and established infrastructure are the main factors
attributing to largest share of central laboratories
- North
America is the most developed clinical laboratory tests market due to
factors such as high awareness levels, rising prevalence of cardiovascular
disorders, and high market penetration of technologically advanced
diagnostic techniques
- Asia
Pacific is anticipated to witness significant growth over 9% during the
forecast period with presence of huge untapped opportunities, increasing
base of target population, and positive economic growth.
- Some of
the key companies are Quest Diagnostics, Millipore Sigma, LabCorp, and
Genoptix Medical Laboratory
- Strategic
initiatives implemented by key players to maintain market position include
merger and acquisition of small players and development of cost effective
clinical tests.
Browse more
reports of this category by Grand View Research: www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the clinical laboratory tests market on the basis of type, end-use, and region.
Type
Outlook (Revenue, USD Billion, 2013 - 2024)
- Complete
blood count
- HGB/HCT
tests
- Basic
metabolic panel tests
- BUN
creatinine tests
- Electrolytes
testing
- HbA1c
tests
- Comprehensive
metabolic panel tests
- Liver
panel tests
- Hepatitis
- Bile
duct obstruction
- Liver
Cirrhosis
- Liver
Cancer
- Bone
disease
- Autoimmune
disorders
- Others
- Renal
panel tests
- Lipid
panel tests
End-use
Outlook (Revenue, USD Billion, 2013 - 2024)
- Central
Laboratories
- Primary
Clinics
Regional
Outlook (Market Revenue in USD Billion, 2013 - 2024)
- North
America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia
Pacific
- Japan
- China
- India
- Latin
America
- Brazil
- Mexico
- Middle
East and Africa
- South
Africa
Access
Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-clinical-laboratory-tests-market
About Grand
View Research:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
Comments
Post a Comment